Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -102,329 | -52,371 | -42,856 | -100,606 | -7,325 |
| Depreciation Amortization | -4,837 | -2,937 | 656 | 159 | N/A |
| Accounts payable and accrued liabilities | 4,269 | -261 | 552 | 557 | 308 |
| Other Working Capital | 11,653 | 3,866 | 3,986 | 298 | 307 |
| Other Operating Activity | 5,029 | 8,639 | 2,509 | 81,631 | -740 |
| Operating Cash Flow | $-86,215 | $-43,064 | $-35,153 | $-17,961 | $-7,450 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 48,043 | -171,653 | 39,346 | -104,080 | N/A |
| PPE Investments | -16 | -18 | -161 | -40 | N/A |
| Investing Cash Flow | $48,027 | $-171,671 | $39,185 | $-104,120 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 30,000 | N/A | N/A | N/A |
| Debt Repayment | -739 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 7,938 | 122,229 | 3,907 | 169,185 | N/A |
| Common Stock Repurchased | -41 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -230 | -476 | 0 | 31,281 | 44,675 |
| Financing Cash Flow | $6,928 | $151,753 | $3,907 | $200,466 | $44,675 |
| Beginning Cash Position | 67,119 | 130,101 | 122,162 | 43,777 | 6,552 |
| End Cash Position | 35,859 | 67,119 | 130,101 | 122,162 | 43,777 |
| Net Cash Flow | $-31,260 | $-62,982 | $7,939 | $78,385 | $37,225 |
| Free Cash Flow | |||||
| Operating Cash Flow | -86,215 | -43,064 | -35,153 | -17,961 | -7,450 |
| Capital Expenditure | -16 | -21 | -161 | -40 | N/A |
| Free Cash Flow | -86,231 | -43,085 | -35,314 | -18,001 | -7,450 |